Philippe Held, founder of the innovative Swiss medtech Dermosafe, discusses the origins behind the company’s game-changing digitalized solutions for detecting skin cancer at an early stage, how the rollout of the technology is progressing, and the importance of patient and physician education.
You founded DermoSafe around five years ago with the idea of detecting skin cancer at an early stage thanks to your very innovative digital health web service, and the fully integrated solution that you provide by connected dermoscopy. Why did you choose this particular niche?
"The idea is not to cut out or remove the dermatologist from the equation because they should be part of the concept."
